NeuralGalaxy

突破脑认知 攻克脑疾病 ,银河脑科学,Neural Science, Brain Research, Solve Brain Disorder, Alzheimer’s, Autism, ALS, Bipolar Disorder, Brain Tumor, Dementia, Depression, Epilepsy, Parkinson’s, Schizophrenia, Stroke,

突破脑认知 攻克脑疾病 ,银河脑科学,Neural Science, Brain Research, Solve Brain Disorder, Alzheimer’s, Autism, ALS, Bipolar Disorder, Brain Tumor, Dementia, Depression, Epilepsy, Parkinson’s, Schizophrenia, Stroke,

Chinese researchers investigate brain activity to develop safer, personalized deep brain stimulation (DBS) for Parkinson’s patients. The study explores how tailored stimulation could improve treatment efficacy while reducing side effects. Findings aim to refine DBS protocols for better patient outcomes.

Apr 2026Parkinson's News TodayNews article

Galaxy Brain Scientific demonstrates that Deep Brain Stimulation (DBS) remodels the SPARK circuit to treat Parkinson’s disease non-invasively. A study led by Prof. Hesheng Liu, the company’s founder and CSO, shows therapeutic efficacy in *Nature Neuroscience*. The approach targets personalized precision treatment without traditional surgical interventions.

Mar 2026PR NewswireNews article

Galaxy Brain Scientific’s research, led by founder and CSO Prof. Hesheng Liu, identifies the core neural circuit linked to Parkinson’s disease in a *Nature*-published study. The findings clarify the disease’s biological mechanism, offering a foundation for precision neural stimulation therapies. The team’s technology enables this breakthrough, potentially reshaping treatment approaches for PD patients.

Feb 2026Yahoo FinanceNews article

Neural Galaxy develops neural circuit mapping to enable tailored brain disease treatments. The company targets China’s 130 million brain disease patients, including 50 million with depression, 15 million with Alzheimer’s, and over 10 million with autism. Brain disorders account for nearly 30% of global disease burden, underscoring the unmet need for precision therapies.

Sep 2023KrASIANews article